Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 1/20 | 0.50 |
| ▸ | ESR1 | P03372 | 4/20 | 0.43 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.36 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10916780 | 0.91 | ESR1 (0.48) | CYP2A6ESR1ESR2TAAR1CYP1A2 | |
| SCHEMBL10915580 | 0.84 | ESR1 (0.44) | CYP2A6ESR1ESR2TAAR1HSD17B10 | |
| SCHEMBL2439497 | 0.83 | ESR1 (0.52) | ESR1ESR2TP53HPGDALDH1A1 | |
| SCHEMBL2439798 | 0.83 | ESR1 (0.43) | CYP2A6ESR1ESR2TAAR1HPGD | |
| SCHEMBL3160096 | 0.81 | ESR1 (0.42) | ESR1ESR2TAAR1HPGDALDH1A1 | |
| SCHEMBL2823833 | 0.81 | SLC6A4 (0.55) | ESR1ESR2TAAR1ALDH1A1KDM4E | |
| SCHEMBL5784144 | 0.80 | SLC6A2 (0.52) | ESR1ESR2TP53TAAR1ALDH1A1 | |
| SCHEMBL14268192 | 0.78 | ALDH1A1 (0.42) | ESR1ESR2TP53ALDH1A1KMT2A | |
| SCHEMBL13938788 | 0.77 | NPC1 (0.40) | ESR1ESR2HPGDALDH1A1ALOX15 | |
| SCHEMBL10914831 | 0.77 | HRH3 (0.38) | CYP2A6ESR1ESR2KDM4ECYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 272 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4695016-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2026-02-18 | — | — | EP | claimed |
| EP-4655373-A1 | BIODEGRADABLE PERFUME COMPOSITION | Givaudan SA (CH) | 2025-12-03 | — | — | EP | claimed |
| WO-2024213507-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2024-10-17 | — | — | WO | claimed |
| EP-4446001-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2024-10-16 | — | — | EP | claimed |
| WO-2024156688-A1 | BIODEGRADABLE PERFUME COMPOSITION | GIVAUDAN SA (CH) | 2024-08-02 | — | — | WO | claimed |
| EP-4407019-A1 | BIODEGRADABLE PERFUME COMPOSITION | Givaudan SA (CH) | 2024-07-31 | — | — | EP | claimed |
| WO-2023160791-A1 | COMBINATIONS OF 2-METHYL-2-OCTANOL WITH PLEASANT SMELLING COMPOUNDS | SYMRISE AG (DE) | 2023-08-31 | — | — | WO | claimed |
| US-20190155975-A9 | Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions | THE PROCTER & GAMBLE COMPANY | 2019-05-23 | — | — | US | claimed |
| EP-3469055-A1 | CLEANING COMPOSITIONS INCLUDING NUCLEASE ENZYME AND MALODOR REDUCTION MATERIALS | The Procter & Gamble Company (US) | 2019-04-17 | — | — | EP | claimed |
| US-10240108-B2 | Particles for malodor reduction | THE PROCTER & GAMBLE COMPANY (US) | 2019-03-26 | — | — | US | claimed |
| EP-2931854-A1 | FRAGRANCE MATERIALS | The Procter & Gamble Company (US) | 2015-10-21 | — | — | EP | claimed |
| CN-104902869-A | Personal care compositions | PROCTER & GAMBLE | 2015-09-09 | — | — | CN | claimed |
| CN-104837973-A | Fragrance materials | PROCTER & GAMBLE | 2015-08-12 | — | — | CN | claimed |
| US-20140179722-A1 | Antiperspirant and Deodorant Compositions | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-26 | — | — | US | claimed |
| US-20140170101-A1 | Antiperspirant and Deodorant Compositions | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | US | claimed |
| US-20140170194-A1 | FRAGRANCE MATERIALS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | US | claimed |
| WO-2014093819-A2 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | WO | claimed |
| WO-2014093807-A1 | FRAGRANCE MATERIALS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | WO | claimed |
| WO-2014093747-A2 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | WO | claimed |
| US-20110020251-A1 | Ultraviolet-Absorbing Compounds | AVOCA LLC | 2011-01-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140170101-A1 | Antiperspirant and Deodorant Compositions | LPO, GPX4, DEK | CYP2A6 842/4885ESR1 2876/4885ESR2 3461/4885 |
| US-20110020251-A1 | Ultraviolet-Absorbing Compounds | UFM1, UHRF1, CUTA | CYP2A6 1512/4885ESR1 807/4885ESR2 1531/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.